| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.15 | 0.002 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.092 | 0.05 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.092 | 0.07 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.08 | 0.1 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.08 | 0.1 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.076 | 0.1 |